HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics plc (NBRV), sold 13,170 shares at $10.51 ($138K) on 2017-07-28, disclosed to the SEC on 2017-08-01.
Open-market sale of $138k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.51 | 6,585 | $69K | 50.0% |
| 2 | $10.51 | 6,585 | $69K | 50.0% |
| Total | $10.51 avg | 13,170 | $138K | 100% |
| Filing → |
| NBRV | SELL | 2017-09-14 | $598K | — | Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |